Trend in Mortality after Stroke with Atrial Fibrillation

American Journal of Medicine

Volumn 120, Issue 1, 2007, Pages 47-53

  Frost, Lars ^a   Andersen, Ljubica Vukelic ^a   Vestergaard, Peter ^a   Husted, Steen ^a   Mortensen, Leif Spange ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNI C   (Denmark)

Author keywords

Arrhythmia; Cohort study; Epidemiology; Mortality

Indexed keywords

ADULT; AGED; ARTICLE; BASIC REPRODUCTION NUMBER; COMORBIDITY; DENMARK; DISEASE REGISTRY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEX DIFFERENCE; STROKE; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CEREBROVASCULAR ACCIDENT; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK FACTORS; SURVIVAL RATE;

EID: 33845909023     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.12.027     Document Type: Article

References (25)

1. Sarti C., Rastenyte D., Cepaitis Z., and Tuomilehto J. International trends in mortality from stroke, 1968 to 1994. Stroke 31 (2000) 1588-1601
2. Feigin V.L., Lawes C.M., Bennett D.A., and Anderson C.S. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2 (2003) 43-53
3. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 147 (1987) 1561-1564
4. Lin H.J., Wolf P.A., Kelly-Hayes M., et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 27 (1996) 1760-1764
5. Dulli D.A., Stanko H., and Levine R.L. Atrial fibrillation is associated with severe acute ischemic stroke. Neuroepidemiology 22 (2003) 118-123
6. Marini C., De Santis F., Sacco S., et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke 36 (2005) 1115-1119
7. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Time trends of ischemic stroke incidence and mortality in patients diagnosed with first atrial fibrillation in 1980 to 2000: report of a community-based study. Stroke 36 (2005) 2362-2366
8. Andersen T.F., Madsen M., Jorgensen J., Mellemkjoer L., and Olsen J.H. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46 (1999) 263-268
9. National Institute of Neurological Disorders and Stroke Ad Hoc Committee. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases: III. Stroke 21 (1990) 637-676
10. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health 79 (1989) 340-349
11. Kjoller E., Mortensen L.S., and Larsen M.E. Evaluation of prognosis. Dan Med Bull 25 (1978) 238-242
12. Rothwell P.M., Coull A.J., Giles M.F., et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363 (2004) 1925-1933
13. Frost L., Vestergaard P., Mosekilde L., and Mortensen L.S. Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. Int J Cardiol 103 (2005) 78-84
14. Frost L., Johnsen S.P., Pedersen L., Toft E., Husted S., and Sorensen H.T. Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice. J Intern Med 252 (2002) 64-69
15. Friberg J., Gislason G.H., Gadsboll N., et al. Temporal trends in the prescription of vitamin K antagonists in patients with atrial fibrillation. J Intern Med 259 (2006) 173-178
16. Hylek E.M., Go A.S., Chang Y., et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 349 (2003) 1019-1026
17. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342 (1993) 1255-1262
18. Nielsen H.W., Tuchsen F., and Jensen M.V. [Validity of the diagnosis "essential hypertension" in the National Patient Registry]. Ugeskr Laeger 158 (1996) 163-167
19. Frost L., and Vestergaard P. Alcohol and risk of atrial fibrillation or flutter: a cohort study. Arch Intern Med 164 (2004) 1993-1998
20. Petersen P., Boysen G., Godtfredsen J., Andersen E.D., and Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet 1 (1989) 175-179
21. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. N Engl J Med 323 (1990) 1505-1511
22. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 84 (1991) 527-539
23. Connolly S.J., Laupacis A., Gent M., Roberts R.S., Cairns J.A., and Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol 18 (1991) 349-355
24. Ezekowitz M.D., Bridgers S.L., James K.E., et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 327 (1992) 1406-1412
25. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 343 (1994) 687-691